Loading the map…

Activities of head offices · Northwich

Dechra Pharmaceuticals

Dechra Pharmaceuticals Limited

Loss-makingActiveLatest figures: 2023Group consolidated29 years on the register

Private limited company registered in Northwich, classed under “Activities of head offices”.

Headline figures

FY to Jun 2023 · Group consolidated

Turnover

For subscribers

Profit after tax

−£27.9m

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

4 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£202120222023
Profit after tax−£27.9m
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet202120222023
Current assets
of which cash
Creditors due within a year
Creditors due after a year
Net assets
Ratios
Profit marginProfit after tax as a share of turnover
Return on equityProfit after tax as a share of net assets
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year

5 balance-sheet lines and 4 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Timeline

Checked 2026-10-18

  1. Shares
    Statement of capital on 9 July 2026 · GBP 22,568,036.23
  2. Shares
    Statement by Directors (and 2 more like it since 28 January 2019)
  3. Notice
    Solvency Statement dated 07/07/26
  4. Filing
    Resolutions (and 7 more like it since 30 October 2019)
  5. Directors
    Appointment of Mr Thomas James Bannister as a secretary on 31 March 2026
  6. Directors
    Termination of appointment of Jonathan David Lang as a director on 31 March 2026
  7. Directors
    Termination of appointment of Melanie Jane Hall as a secretary on 31 March 2026
  8. Accounts
    Audit exemption subsidiary accounts made up to 30 June 2025
  9. Accounts
    Consolidated accounts of parent company for subsidiary company period ending 30/06/25
  10. Accounts
    Notice of agreement to exemption from audit of accounts for period ending 30/06/25
  11. Ownership
    Change of details for Dechra Pharmaceuticals Holdings Limited as a person with significant control on 15 February 2024
  12. Directors
    Termination of appointment of Paul Nicholas Sandland as a director on 31 March 2025
  13. 26 earlier
    1. Directors
      Appointment of Mr Ajay Gandhi as a director on 5 March 2025
    2. Accounts
      Full accounts made up to 30 June 2024
    3. Charges
      Registration of charge 033696340014, created on 22 January 2025
    4. Charges
      Satisfaction of charge 033696340013 in full
    5. Charges
      Satisfaction of charge 033696340012 in full
    6. Shares
      Statement of capital following an allotment of shares on 30 August 2024 · GBP 22,568,036.23 (and 29 more like it since 14 March 2019)
    7. Ownership
      Change of details for Freya Bidco Limited as a person with significant control on 8 March 2024
    8. Directors
      Appointment of Mr Jesper Due Nordengaard as a director on 26 June 2024
    9. Directors
      Termination of appointment of Ian David Page as a director on 10 June 2024
    10. Directors
      Appointment of Mr Jonathan David Lang as a director on 10 June 2024
    11. Charges
      Registration of charge 033696340013, created on 29 April 2024
    12. Charges
      Registration of charge 033696340012, created on 29 April 2024
    13. Ownership
      Notification of Freya Bidco Limited as a person with significant control on 15 February 2024
    14. Filing
      Court order
    15. Filing
      Re-registration of Memorandum and Articles
    16. Name
      Certificate of re-registration from Public Limited Company to Private
    17. Name
      Re-registration from a public company to a private limited company
    18. Directors
      Termination of appointment of John Francis Shipsey as a director on 16 January 2024
    19. Directors
      Termination of appointment of Elizabeth Alison Platt as a director on 16 January 2024
    20. Directors
      Termination of appointment of Lawson Macartney as a director on 16 January 2024
    21. Directors
      Termination of appointment of Geeta Gopalan as a director on 16 January 2024
    22. Directors
      Termination of appointment of Lisa Jane Bright as a director on 16 January 2024
    23. Accounts
      Group of companies' accounts made up to 30 June 2023
    24. Directors
      Termination of appointment of Anthony Gerard Griffin as a director on 27 November 2023
    25. Filing
      Memorandum and Articles of Association
    26. Directors
      Termination of appointment of Ishbel Jean Stewart Macpherson as a director on 22 June 2023

From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.

Questions people ask

›What does Dechra Pharmaceuticals do?

Private limited company registered in Northwich, classed under “Activities of head offices”.

›How much turnover does Dechra Pharmaceuticals make?

Answered in the full report

›Is Dechra Pharmaceuticals profitable?

No: it made a loss after tax of £27.9m in the year to 30 June 2023, its latest filed accounts.

›Who runs and owns Dechra Pharmaceuticals?

Its directors are Thomas James Bannister, Ajay Gandhi, Jesper Due Nordengaard. Its owners are shown to subscribers.

›Where is Dechra Pharmaceuticals based?

Its registered office is 24 Cheshire Avenue Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA, in Northwich.

›When was Dechra Pharmaceuticals founded?

Dechra Pharmaceuticals Limited was incorporated on 13 May 1997.

›Is Dechra Pharmaceuticals still trading?

The register lists Dechra Pharmaceuticals Limited as active.

More companies in Northwich →